Inhibition of mitochondrial function by metformin increases glucose uptake, glycolysis and GDF-15 release from intestinal cells

Even though metformin is widely used to treat type2 diabetes, reducing glycaemia and body weight, the mechanisms of action are still elusive. Recent studies have identified the gastrointestinal tract as an important site of action. Here we used intestinal organoids to explore the effects of metformi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Ming, Darwish, Tamana, Larraufie, Pierre, Rimmington, Debra, Cimino, Irene, Goldspink, Deborah A., Jenkins, Benjamin, Koulman, Albert, Brighton, Cheryl A., Ma, Marcella, Lam, Brian Y. H., Coll, Anthony P., O’Rahilly, Stephen, Reimann, Frank, Gribble, Fiona M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843649/
https://www.ncbi.nlm.nih.gov/pubmed/33510216
http://dx.doi.org/10.1038/s41598-021-81349-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843649/
https://www.ncbi.nlm.nih.gov/pubmed/33510216
http://dx.doi.org/10.1038/s41598-021-81349-7

Ejemplares similares